MWNA
Marshall Wace North America Portfolio holdings
AUM
$23.3B
1-Year Return
46.22%
This Quarter Return
+9.81%
1 Year Return
+46.22%
3 Year Return
+108.24%
5 Year Return
–
10 Year Return
–
AUM
$23.8B
AUM Growth
-$298M
(-1.2%)
Cap. Flow
-$2.32B
Cap. Flow
% of AUM
-9.77%
Top 10 Holdings %
Top 10 Hldgs %
24.05%
Holding
1,984
New
497
Increased
347
Reduced
441
Closed
584
Top Buys
| 1 |
Johnson & Johnson
JNJ
|
+$156M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$144M |
| 3 |
Salesforce
CRM
|
+$143M |
| 4 |
IBM
IBM
|
+$133M |
| 5 |
Dell
DELL
|
+$115M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$333M |
| 2 |
Apple
AAPL
|
+$218M |
| 3 |
Intel
INTC
|
+$175M |
| 4 |
Zoom
ZM
|
+$171M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$163M |
Sector Composition
| 1 | Healthcare | 23.6% |
| 2 | Technology | 18.15% |
| 3 | Communication Services | 13.77% |
| 4 | Consumer Discretionary | 12.83% |
| 5 | Financials | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
401
Labcorp
LH
$23B
| $8.63M | 0.04% |
36,424
+30,145
| +480% | +$7.14M |
|
402
POSCO
PKX
$15.4B
| $8.55M | 0.04% |
111,377
+39,718
| +55% | +$3.05M |
|
403
Cartesian Therapeutics
RNAC
$265M
| $8.54M | 0.04% |
68,125
-28,482
| -29% | -$3.57M |
|
404
M&T Bank
MTB
$31.1B
| $8.52M | 0.04% |
58,615
-13,529
| -19% | -$1.97M |
|
405
Allogene Therapeutics
ALLO
$253M
| $8.48M | 0.04% |
+325,040
| New | +$8.48M |
|
406
PACCAR
PCAR
$51.6B
| $8.47M | 0.04% |
142,359
+47,808
| +51% | +$2.84M |
|
407
Lamb Weston
LW
$8.02B
| $8.35M | 0.03% |
103,486
-35,443
| -26% | -$2.86M |
|
408
Avidity Biosciences
RNA
$6.18B
| $8.31M | 0.03% |
+336,455
| New | +$8.31M |
|
409
Mercury Systems
MRCY
$4.12B
| $8.3M | 0.03% |
125,249
-117,820
| -48% | -$7.81M |
|
410
Nike
NKE
$109B
| $8.26M | 0.03% |
53,496
-20,581
| -28% | -$3.18M |
|
411
Entegris
ENTG
$12.3B
| $8.17M | 0.03% |
+66,445
| New | +$8.17M |
|
412
UBS Group
UBS
$128B
| $8.13M | 0.03% |
+530,089
| New | +$8.13M |
|
413
TaskUs
TASK
$1.64B
| $8.13M | 0.03% |
+237,483
| New | +$8.13M |
|
414
American International
AIG
$43.5B
| $8.05M | 0.03% |
+169,196
| New | +$8.05M |
|
415
Alaska Air
ALK
$7.34B
| $8.02M | 0.03% |
+132,928
| New | +$8.02M |
|
416
Valero Energy
VLO
$48.9B
| $8M | 0.03% |
102,428
-36,709
| -26% | -$2.87M |
|
|
KCAC
417
DELISTED
Kensington Capital Acquisition Corp. II
KCAC
| $7.96M | 0.03% |
+800,000
| New | +$7.96M |
|
|
PRPB
418
DELISTED
CC Neuberger Principal Holdings II Class A Ordinary Shares
PRPB
| $7.91M | 0.03% |
800,000
| – | – |
|
419
Bank of Montreal
BMO
$90.9B
| $7.82M | 0.03% |
76,250
-195,230
| -72% | -$20M |
|
420
ESSA Pharma
EPIX
$11.4M
| $7.81M | 0.03% |
273,413
+91,386
| +50% | +$2.61M |
|
421
Consolidated Edison
ED
$34.9B
| $7.79M | 0.03% |
108,593
+68,233
| +169% | +$4.89M |
|
|
CERN
422
DELISTED
Cerner Corp
CERN
| $7.77M | 0.03% |
99,359
-13,664
| -12% | -$1.07M |
|
423
MPLX
MPLX
$51.1B
| $7.75M | 0.03% |
261,869
-425,690
| -62% | -$12.6M |
|
424
RTX Corp
RTX
$203B
| $7.69M | 0.03% |
90,151
-107,544
| -54% | -$9.17M |
|
425
Xenon Pharmaceuticals
XENE
$2.89B
| $7.66M | 0.03% |
+411,259
| New | +$7.66M |
|